Showing results (121-130 of 149) with videos related to
Sort By:
Pageof 15
Communications Medicine|January 20, 2023
Serum biomarker-based early detection of pancreatic ductal adenocarcinomas with ensemble learningNuno R Nené, Alexander Ney, Tatiana Nazarenko, et al.Gynecologic Oncology|June 21, 2020
Ovarian cancer symptoms, routes to diagnosis and survival - Population cohort study in the 'no screen' arm of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)James Dilley, Matthew Burnell, Aleksandra Gentry-Maharaj, et al.Hereditary Cancer in Clinical Practice|November 25, 2011
Screening for ovarian cancer in women with varying levels of risk, using annual tests, results in high recall for repeat screening testsMarielle Ae Nobbenhuis, Elizabeth Bancroft, Eleanor Moskovic, et al.Human Molecular Genetics|March 10, 2009
Functional complementation studies identify candidate genes and common genetic variants associated with ovarian cancer survivalLydia Quaye, Dimitra Dafou, Susan J Ramus, et al.Journal of the National Cancer Institute|December 2, 2014
Population testing for cancer predisposing BRCA1/BRCA2 mutations in the Ashkenazi-Jewish community: a randomized controlled trialRanjit Manchanda, Kelly Loggenberg, Saskia Sanderson, et al.Trials|January 26, 2021
Completeness and accuracy of national cancer and death registration for outcome ascertainment in trials-an ovarian cancer exemplarJatinderpal K Kalsi, Andy Ryan, Aleksandra Gentry-Maharaj, et al.International Journal of Cancer|January 28, 2016
Protein Z: A putative novel biomarker for early detection of ovarian cancerMatthew R Russell, Michael J Walker, Andrew J K Williamson, et al.Journal of Medical Genetics|March 20, 2016
Cluster-randomised non-inferiority trial comparing DVD-assisted and traditional genetic counselling in systematic population testing for BRCA1/2 mutationsRanjit Manchanda, Matthew Burnell, Kelly Loggenberg, et al.Journal of the National Cancer Institute|December 2, 2014
Cost-effectiveness of population screening for BRCA mutations in Ashkenazi jewish women compared with family history-based testingRanjit Manchanda, Rosa Legood, Matthew Burnell, et al.Cancers|March 6, 2021
Performance Characteristics of the Ultrasound Strategy during Incidence Screening in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)Jatinderpal Kalsi, Aleksandra Gentry-Maharaj, Andy Ryan, et al.Pageof 15